These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 26030922)

  • 21. Private demand for cholera vaccines in Hue, Vietnam.
    Kim D; Canh DG; Poulos C; Thoa LT; Cook J; Hoa NT; Nyamete A; Thuy DT; Deen J; Clemens J; Thiem VD; Anh DD; Whittington D
    Value Health; 2008; 11(1):119-28. PubMed ID: 18237366
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Community acceptance and willingness-to-pay for a hypothetical Zika vaccine: A cross-sectional study in Indonesia.
    Harapan H; Mudatsir M; Yufika A; Nawawi Y; Wahyuniati N; Anwar S; Yusri F; Haryanti N; Wijayanti NP; Rizal R; Fitriani D; Maulida NF; Syahriza M; Ikram I; Fandoko TP; Syahadah M; Asrizal FW; Aletta A; Jamil KF; Rajamoorthy Y; Hadisoemarto PF; Wagner AL; Groneberg DA; Kuch U; Sasmono RT; Müller R; Imrie A
    Vaccine; 2019 Mar; 37(11):1398-1406. PubMed ID: 30739794
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The private demand for Hib vaccination in a probable low Hib disease incidence country: Thailand 2006.
    Muangchana C; Bishai D
    Southeast Asian J Trop Med Public Health; 2010 Jul; 41(4):883-99. PubMed ID: 21073063
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A prospective cohort study to assess seroprevalence, incidence, knowledge, attitudes and practices, willingness to pay for vaccine and related risk factors in dengue in a high incidence setting.
    Martínez-Vega RA; Rodriguez-Morales AJ; Bracho-Churio YT; Castro-Salas ME; Galvis-Ovallos F; Díaz-Quijano RG; Luna-González ML; Castellanos JE; Ramos-Castañeda J; Diaz-Quijano FA
    BMC Infect Dis; 2016 Nov; 16(1):705. PubMed ID: 27887591
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Economic Evaluations of Dengue Vaccination in the Southeast Asia Region: Evidence From a Systematic Review.
    Supadmi W; Suwantika AA; Perwitasari DA; Abdulah R
    Value Health Reg Issues; 2019 May; 18():132-144. PubMed ID: 31082793
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Dengue vaccine acceptance and willingness to pay: a systematic review and meta-analysis.
    Orellano P; Reynoso J; Salomón OD; Vezzani D
    Public Health; 2023 Nov; 224():74-81. PubMed ID: 37741155
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cost of production of live attenuated dengue vaccines: a case study of the Instituto Butantan, Sao Paulo, Brazil.
    Mahoney RT; Francis DP; Frazatti-Gallina NM; Precioso AR; Raw I; Watler P; Whitehead P; Whitehead SS
    Vaccine; 2012 Jul; 30(32):4892-6. PubMed ID: 22406455
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Household costs of hospitalized dengue illness in semi-rural Thailand.
    Tozan Y; Ratanawong P; Sewe MO; Wilder-Smith A; Kittayapong P
    PLoS Negl Trop Dis; 2017 Sep; 11(9):e0005961. PubMed ID: 28937986
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Factors associated with the willingness of primary caregivers to avail of a dengue vaccine for their 9 to 14-year-olds in an urban community in the Philippines.
    Reyes MSGL; Lee KMG; Pedron AML; Pimentel JMT; Pinlac PAV
    Vaccine; 2020 Jan; 38(1):54-62. PubMed ID: 31668819
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Economic value of dengue vaccine in Thailand.
    Lee BY; Connor DL; Kitchen SB; Bacon KM; Shah M; Brown ST; Bailey RR; Laosiritaworn Y; Burke DS; Cummings DA
    Am J Trop Med Hyg; 2011 May; 84(5):764-72. PubMed ID: 21540387
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Preference and willingness to pay for reproductive health services among adults in Urban-Rural transition settings of a developing country: evidence from a cross-sectional study in a rural district of Hanoi, Vietnam.
    Nguyen NTT; Nguyen LH; Nguyen TT; Vu LG; Vu TMT; Le Vu MN; Vu GT; Latkin CA; Ho CSH; Ho RCM
    BMC Health Serv Res; 2023 Nov; 23(1):1196. PubMed ID: 37919709
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Current issues in the economics of vaccination against dengue.
    Tozan Y
    Expert Rev Vaccines; 2016; 15(4):519-28. PubMed ID: 26642099
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Projected costs associated with school-based screening to inform deployment of Dengvaxia: Vietnam as a case study.
    Turner HC; Wills BA; Rahman M; Quoc Cuong H; Thwaites GE; Boni MF; Clapham HE
    Trans R Soc Trop Med Hyg; 2018 Aug; 112(8):369-377. PubMed ID: 29982700
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Policymakers' views on dengue fever/dengue haemorrhagic fever and the need for dengue vaccines in four southeast Asian countries.
    DeRoeck D; Deen J; Clemens JD
    Vaccine; 2003 Dec; 22(1):121-9. PubMed ID: 14604579
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Private Demand for Covid-19 Vaccine: A Contingent Assessment from a Low-and Middle-income Country.
    Meshkani Z; Zarei L; Hajimoladarvish N; Arabloo J; Rezapour A; Farabi H; Moradi N
    Iran J Pharm Res; 2021; 20(3):223-234. PubMed ID: 34903984
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The economic promise of developing and implementing dengue vaccines: Evidence from a systematic review.
    Endo IC; Ziegelmann PK; Patel A
    Vaccine; 2016 Dec; 34(50):6133-6147. PubMed ID: 27810313
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Immunization coverage of children aged 0 to 5 years in Libreville (Gabon)].
    Ategbo S; Ngoungou EB; Koko J; Vierin Y; Zang Ndong CE; Moussavou Mouyama A
    Sante; 2010; 20(4):215-9. PubMed ID: 21266317
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Valuing a hypothetical cure for rheumatoid arthritis using the contingent valuation methodology: the patient perspective.
    Fautrel B; Clarke AE; Guillemin F; Adam V; St-Pierre Y; Panaritis T; Fortin PR; Menard HA; Donaldson C; Penrod JR
    J Rheumatol; 2005 Mar; 32(3):443-53. PubMed ID: 15742435
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Symptomatic Dengue in Children in 10 Asian and Latin American Countries.
    L'Azou M; Moureau A; Sarti E; Nealon J; Zambrano B; Wartel TA; Villar L; Capeding MR; Ochiai RL; ;
    N Engl J Med; 2016 Mar; 374(12):1155-66. PubMed ID: 27007959
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Impact of dengue virus infection and its control.
    Igarashi A
    FEMS Immunol Med Microbiol; 1997 Aug; 18(4):291-300. PubMed ID: 9348165
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.